OG1.1-5 | Demographic and Vital Statistics — Graded Quiz

Correct. MMR = (18 / 21,500) × 100,000 = 83.7 per 100,000 live births. The denominator is live births, not total deliveries. Options B and C use an incorrect denominator or multiplier; option D is numerically equivalent to option C but expressed per 1,000.

MMR calculation: numerator = maternal deaths; denominator = live births; multiplier = 100,000. Common error = using total deliveries or total births instead of live births.

Incorrect. MMR = (maternal deaths / live births) × 100,000. Using 21,500 live births: (18/21,500) × 100,000 = 83.7. The denominator must be live births, not total deliveries; and the multiplier is 100,000.

Correct. An indirect maternal death results from a pre-existing disease or a disease that develops during pregnancy, not directly due to obstetric causes, but which is aggravated by the physiological effects of pregnancy. Rheumatic mitral stenosis worsened by the increased cardiac demand of pregnancy is the classic example. It is not direct (no obstetric complication) and not coincidental (pregnancy causally contributed).

Indirect maternal death: pre-existing disease aggravated by pregnancy (cardiac disease = classic). Direct: obstetric cause. Coincidental: unrelated. Late: 42 days to 1 year postpartum.

Incorrect. Indirect maternal death = pre-existing/new non-obstetric disease worsened by pregnancy (e.g. cardiac disease, tuberculosis). Direct = obstetric cause (eclampsia, PPH, sepsis). Coincidental = unrelated cause (road accident). Late maternal death = 42 days to 1 year postpartum — this death was antenatal, so 'late' does not apply.

Correct. PMR = (stillbirths ≥28 wks + early neonatal deaths) / total births × 1,000 = (5 + 12) / 2,400 × 1,000 = 17/2,400 × 1,000 = 7.08 per 1,000 total births. PMR uses total births (live + stillbirths) in the denominator, unlike NMR which uses live births.

PMR = (late fetal deaths ≥28 wks + early neonatal deaths days 0–6) / total births × 1,000. Denominator = total births. Neonatal mortality rate uses live births only.

Incorrect. PMR numerator = stillbirths (≥28 wks) + early neonatal deaths (days 0–6). Denominator = total births (live births + stillbirths). PMR = (5+12)/2,400 × 1,000 = 7.08. Option A counts only stillbirths; option C and D use live births only in the denominator.

Correct. The primary purpose of perinatal mortality audit is to identify avoidable (modifiable) factors in deaths and translate findings into quality improvement — better protocols, training, equipment, or referral pathways. It is a confidential, blame-free process. Legal attribution and accreditation compliance may be secondary uses but are not the driving purpose.

Perinatal mortality audit = confidential, blame-free quality improvement. Identifies avoidable factors → protocol and practice change. Same principle applies to maternal death review (MDR).

Incorrect. Perinatal audit is a quality improvement tool, not a legal or financial instrument. Its cardinal principle is confidentiality and a non-punitive, systems-focused approach. The end goal is identifying avoidable factors and improving care.

Correct. This fetus is 380 g (< 500 g) and delivered at 22 weeks (<28 completed weeks) — both criteria meet the definition of abortion. Both conditions (weight < 500 g AND gestational age < 20–28 weeks) contribute; whichever threshold is met first applies. Stillbirth requires ≥28 weeks and ≥1,000 g. Perinatal period starts at 28 weeks. The event is an abortion (specifically a mid-trimester/late abortion).

22 weeks / 380 g = abortion (both below the stillbirth threshold). Stillbirth: ≥28 wks, ≥1,000 g, no signs of life. Getting these thresholds correct is essential for death classification and certification.

Incorrect. Stillbirth requires delivery at ≥28 completed weeks with no signs of life. This fetus at 22 weeks weighing 380 g does not meet either criterion. It is classified as an abortion. Perinatal death requires the perinatal period (≥28 weeks), so that classification does not apply here.

Correct. Group 5 comprises women with at least one previous uterine scar, term singleton cephalic — the defining pathway is repeat CS in women with a prior CS. The most effective intervention is structured TOLAC counselling with vaginal birth after caesarean (VBAC) support, which directly reduces repeat CS in this group. ECV (option A) targets Group 6/7 breech; reducing induction (option C) targets Group 2; twin CS policy (option D) targets Group 8.

Group 5 CS rate reduction = TOLAC/VBAC programme. ECV = Groups 6/7. Induction reduction = Group 2. Each Robson group needs a group-specific intervention strategy.

Incorrect. Group 5 = previous uterine scar, term singleton cephalic. The cycle of repeat CS can only be broken by increasing TOLAC/VBAC. ECV addresses breech presentations (Groups 6 and 7), not Group 5. Reducing induction affects Group 2, and twin policy affects Group 8.

Correct. Robson Group 1: nulliparous (primigravida), singleton, cephalic, ≥37 weeks, in spontaneous labour. Group 2 includes nulliparous women who are induced or deliver by pre-labour CS. Group 3 is multiparous (no previous uterine scar) with spontaneous labour. Group 4 is multiparous (no scar) with induction or pre-labour CS.

Groups 1–4 cover term singleton cephalic: 1=nullip+spontaneous, 2=nullip+induced/pre-labour CS, 3=multip (no scar)+spontaneous, 4=multip (no scar)+induced/pre-labour CS.

Incorrect. Group 1 = nulliparous, singleton cephalic, term, spontaneous labour. Group 2 would apply if she were induced or delivered by pre-labour CS. Groups 3 and 4 apply to multiparous women. Accurate group assignment is essential for a valid CS audit.

Correct. JSY is a conditional cash transfer explicitly tied to institutional delivery. The benefit is not payable for home deliveries, regardless of BPL status or TBA attendance. Institutional delivery — in a government or accredited private facility — is the non-negotiable condition.

JSY condition = institutional delivery in government/accredited private facility. Home deliveries do not qualify. ASHA gets her own incentive for accompanying the woman to the institution, not for home deliveries.

Incorrect. JSY's defining condition is institutional delivery. A home delivery, even with an ASHA present, does not qualify for the JSY cash benefit. The scheme was specifically designed to move deliveries away from home into institutions.

Correct. The RBD Amendment Act 2023 significantly upgraded the status of the birth certificate: it is now the single document of proof for a range of purposes including Aadhaar enrolment, voter ID, school admissions, passports, driving licences, and government schemes. Birth registration was already compulsory under the 1969 Act; the 2023 amendment enhanced the utility and linkage of the certificate.

RBD Act 1969 = mandatory civil registration. 2023 Amendment = birth certificate as single proof document for Aadhaar, voter ID, school admissions, passports. Important for understanding India's civil registration system in context.

Incorrect. Birth registration was already compulsory under the original RBD Act 1969 — not introduced for the first time in 2023. The 2023 amendment's major change is establishing the birth certificate as a universal document of proof for multiple services. Death registration timelines and institutional death rules were governed by the original Act.

Correct. Under AMB and the NHM antenatal care package, pregnant women receive daily oral IFA supplementation throughout pregnancy — providing 180 tablets across the antenatal period (starting as early as 12–14 weeks). Weekly IFA is used for adolescent girls (WIFS programme), not for pregnant women. IV iron is reserved for severe anaemia or oral intolerance; it is not routine for all pregnant women.

AMB for pregnant women = daily IFA (180 tablets) throughout pregnancy. Adolescent girls (WIFS) = weekly IFA. IV iron = severe/refractory anaemia only. De-worming (albendazole) is also part of the AMB package for pregnant women after first trimester.

Incorrect. Weekly IFA (WIFS) is for adolescent girls, not pregnant women. Pregnant women under AMB receive DAILY IFA supplementation throughout pregnancy (180 tablets total). IV iron infusion is not given routinely to all pregnant women — it is reserved for severe anaemia or failure of oral therapy.

Correct. JSSK (launched 2011) provides an entitlement package to pregnant women at government health facilities including: free and cashless delivery, free essential drugs, free diagnostics, free blood products, free diet during hospital stay, free transport from home to facility (and back), and free treatment for sick newborns. The cash-transfer benefit described in option A is JSY — a different but complementary programme.

JSY = cash transfer for institutional delivery. JSSK (2011) = free services at government facility: drugs + diagnostics + blood + diet + transport. Know both programmes and their distinct benefits.

Incorrect. The cash transfer (Rs. 1,400 urban / Rs. 700 rural in LPS) is JSY, not JSSK. JSSK is a service entitlement — it provides free drugs, diagnostics, blood, diet, and transport. The distinction between JSY (cash) and JSSK (service guarantee) is frequently tested.

Correct. SDG Target 3.1 is to reduce the global MMR to less than 70 per 100,000 live births by 2030. India at 97 (2018–20) has made substantial progress (from 254 in 2004–06) but needs continued reduction to meet this goal. India has set its own national target of MMR ≤100 by 2020 (achieved) and MMR <70 by 2030.

SDG 3.1 = MMR <70 per 100,000 live births by 2030. India's trajectory: 254 (2004–06) → 178 (2010–12) → 130 (2014–16) → 97 (2018–20). On track but must continue reduction.

Incorrect. The SDG maternal mortality target (Target 3.1) is an MMR below 70 per 100,000 live births by 2030. India at 97 (2018–20) has already crossed the intermediate target of ≤100 but has further work to reach below 70. Option A represents the intermediate national target already surpassed.